³Ô¹ÏºÚÁÏ

IB Knowledge

³Ô¹ÏºÚÁÏ Business School's thought leadership platform

Jasmin Moshfegh on the economics of healthcare innovation

By Shamita Harsh

Dr Moshfegh discusses how her research in precision medicine is aimed at reducing health inequalities.

Jasmin Moshfegh
Jasmin Moshfegh

Understanding how new medical technologies diffuse through health systems, especially including who gets access to them, is central to Dr Jasmin Moshfegh’s research. Joining ³Ô¹ÏºÚÁÏ Business School in 2025 as Assistant Professor of Economics & Public Policy, she brings a research agenda that sits at the intersection of health economics and healthcare innovation.

How precision medicine and health equity intersect

Her work examines the causes and consequences of healthcare innovation, with a focus on precision medicine, AI and assisted reproductive technologies. By combining quasi-experimental methods with large administrative datasets and cancer registries, she sheds light on how institutional and policy choices shape both efficiency and equity in healthcare delivery.

Her , supported by the US Agency for Healthcare Research and Quality (AHRQ), studies the adoption of genomic testing in breast cancer care—showing that while precision medicine can reduce unnecessary treatments, it may also exacerbate racial disparities.

Dr Moshfegh completed her PhD in Health Policy (Economics) at Stanford University, where she was also a T32 Fellow and R36 awardee from AHRQ. She went on to hold a Postdoctoral Fellowship at Stanford, alongside appointments as a Fellow at the US Department of Veterans Affairs and the National Cancer Institute at the National Institutes of Health. Her research has been supported by grants from the Agency for Healthcare Research and Quality, the SIEPR George P. Shultz Fund and the Sweden-America Foundation.

Extending research into new frontiers

Dr Moshfegh studies the causes and consequences of healthcare innovation, with a particular focus on information technologies. She is extending her work to explore the impact of next-generation diabetes drugs in the US Veterans population and the role of AI tools in improving women’s health in India.

Reflecting on her move to London, she said: “What excites me most about joining ³Ô¹ÏºÚÁÏ is the opportunity to be part of a department and institution that sits at the intersection of cutting-edge research, interdisciplinary collaboration, and real-world impact. ³Ô¹ÏºÚÁÏ’s unique ecosystem brings these disciplines together in a way that few other places can.”

Read about the new faculty joining the Business School

Explore our latest faculty appointments.

Get monthly insights from the ³Ô¹ÏºÚÁÏ Business School team.

Subscribe to the IB Knowledge newsletter